Sign inJoin waitlistJoin the waitlist

Perry Morocco

Associate Program Director, Pediatric Hematology/Oncology Fellowship · Pritzker School of Medicine

Credentials: · · ·

History

Pediatric Hematology/Oncology Fellowship · Pritzker School of Medicine
Present
Pediatric Hematology/Oncology Fellowship · Pritzker School of Medicine
Present
Pritzker School of Medicine
Present

Pediatric Hematology/Oncology
University of Chicago Medical Center
2018–2021
Pediatrics
Saint Louis University Cardinal Glennon Children's Hospital Pediatric
2015–2018
Northwestern University Feinberg School of Medicine
2011–2015

Research

Pediatric Acute Lymphoblastic Leukemia, Version 2.2025, NCCN Clinical Practice Guidelines In Oncology
Journal of the National Comprehensive Cancer Network · 2025 · 30 citations
Disorders of Coagulation in the Newborn
Review · NeoReviews · 2024 · Last of 4 authors · 4 citations
Exudative Retinal Detachment Following Chimeric Antigen Receptor T-Cell Therapy in Relapsed B-Cell Acute Lymphoblastic Leukemia
Case report · Ophthalmic surgery · 2022 · 3 citations

James LaBelle
2 papers
Karyssa Knopoff
2 papers · 2 as a fellow
Lorena Ostilla
2 papers · 2 as a fellow
AM
Anna Mackin
1 paper
BS
Bijal Shah
1 paper
Bradley Muller
1 paper
Carrie Kitko
1 paper
Cathy Lee-Miller
1 paper · 1 as a fellow
Colleen Annesley
1 paper
DD
David Dao
1 paper · 1 as a fellow
David Mangum
1 paper
David McCall
1 paper

Clinical trials

A Study With Tovorafenib (DAY101) as a Treatment Option for Progressive, Relapsed, or Refractory Langerhans Cell Histiocytosis
Site PI · Recruiting · Phase 2
National Cancer Institute (NCI)
2024–2028
A Study to Compare Standard Therapy to Treat Hodgkin Lymphoma to the Use of Two Drugs, Brentuximab Vedotin and Nivolumab
Site PI · Recruiting · Phase 3
National Cancer Institute (NCI)
2023–2031